Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAOCHE3: Endovascular Therapy for Basilar Artery Occlusion with Large Core Infarct
NCT07046299Not yet recruiting
- Sponsor
- Capital Medical University
- Start
- Jul 2025
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
Randomised, open-label trial in basilar artery occlusion (BAO) and ischemic stroke (2 arms), sponsored by Capital Medical University. Primary endpoint: Proportion of Patients Achieving mRS 0-3 at 90 Days. Planned start Jul 2025; status: not yet recruiting.
02
Conditions
basilar artery occlusion (BAO)ischemic stroke
Beyond the preview
Go deeper on NCT07046299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07046299.